ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»10.15690/pf.v12i2.1284ppharm-10Research ArticleНЕОТЛОЖНЫЕ СОСТОЯНИЯ У ДЕТЕЙEMERGENCY CONDITIONS IN CHILDRENКЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ ПО ДИАГНОСТИКЕ СЕПСИСА У ДЕТЕЙCLINICAL RECOMMENDATIONS FOR DIAGNOSING SEPSIS IN CHILDRENТепаевР. Ф.TepaevR. F.tepaev@nczd.ruНаучный центр здоровья детей, Москва, Российская Федерация Первый Московский государственный медицинский университет им. И.М. Сеченова, Российская ФедерацияРоссияScientific Center of Children’s Health, Moscow, Russia Sechenov First State Medical University, Moscow, RussiaRussian Federation201519042015122Педиатрическая фармакология205208Copyright © Тепаев Р.Ф., 20152015Тепаев Р.Ф.Tepaev R.F.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/10

Сепсис является одной из ведущих причин летальности детей. Своевременная диагностика ― важнейшее условие успешной терапии сепсиса. В работе представлен анализ рекомендаций по диагностике синдрома системного воспалительного ответа, сепсиса, тяжелого сепсиса и септического шока Согласительной конференции Американского общества торакальных врачей, Общества медицины критических состояний (1992), Международной согласительной конференции педиатров по сепсису (2005), Международной организации «Движение за выживание при сепсисе» (Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012), опубликованых в 2013 г. Освещены современные представления о физиологии системного воспаления при сепсисе и «стерильном» воспалении.

Sepsis is one of the leading causes of child lethality. Timely diagnostics is the most important condition for treating sepsis successfully. This study contains analysis of recommendations on diagnosing the syndrome of systemic inflammatory response, sepsis, severe sepsis and septic shock of the Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012,published in 2013. The modern perceptions of systemic inflammation during sepsis and sterile inflammation are highlighted.

синдром системного воспалительного ответасепсиссептический шокдетиsystemic inflammatory response syndromesepsisseptic shockchildrenReferencesAmerican College of Chest Physicians / Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992 Jun; 20 (6): 864−74.American College of Chest Physicians / Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992 Jun; 20 (6): 864−74.Goldstein B., Giroir B., Randolph A. Members of the International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6: 2−8.Goldstein B., Giroir B., Randolph A. Members of the International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6: 2−8.Dellinger R.P., Levy M.M., Rhodes A. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med. 2013; 41: 580−637.Dellinger R.P., Levy M.M., Rhodes A. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med. 2013; 41: 580−637.Sprung C.L., Sakr Y., Vincent J.L., Le Gall J.R., Reinhart K., Ranieri V.M., Gerlach H., Fielden J., Groba C.B., Payen D. An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence in Acutely ill Patients (SOAP) study. Intensive Care Med. 2006; 32: 421–427.Sprung C.L., Sakr Y., Vincent J.L., Le Gall J.R., Reinhart K., Ranieri V.M., Gerlach H., Fielden J., Groba C.B., Payen D. An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence in Acutely ill Patients (SOAP) study. Intensive Care Med. 2006; 32: 421–427.Andersson U., Tracey K.J. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011; 29: 139–62.Andersson U., Tracey K.J. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011; 29: 139–62.Nathan C., Ding A. Nonresolving inflammation. Cell. 2010; 140: 871–82.Nathan C., Ding A. Nonresolving inflammation. Cell. 2010; 140: 871–82.

The authors declare that there are no conflicts of interest present.